BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fraser CG. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies. Gastroenterol Hepatol 2019;42:263-70. [PMID: 30459060 DOI: 10.1016/j.gastrohep.2018.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Benton SC, Fraser CG. Faecal immunochemical tests in the COVID-19 pandemic; safety-netting of patients with symptoms and low faecal haemoglobin concentration - can a repeat test be used? Ann Clin Biochem 2021;58:163-5. [PMID: 33016079 DOI: 10.1177/0004563220967569] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Pin-Vieito N, Puga M, Fernández-de-Castro D, Cubiella J. Faecal immunochemical test outside colorectal cancer screening? World J Gastroenterol 2021; 27(38): 6415-6429 [PMID: 34720531 DOI: 10.3748/wjg.v27.i38.6415] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kearsey CC, Graham C, Lobb HS, Chacko J, Weatherburn R, Rooney PS. Cost effectiveness of using Faecal Immunochemical Testing (FIT) as an initial diagnostic investigation for patients with lower gastrointestinal symptoms suggestive of malignancy. BMC Fam Pract 2021;22:90. [PMID: 33980161 DOI: 10.1186/s12875-021-01435-7] [Reference Citation Analysis]
4 Chapman C, Thomas C, Morling J, Tangri A, Oliver S, Simpson JA, Humes DJ, Banerjea A. Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham. Colorectal Dis 2020;22:679-88. [PMID: 31876975 DOI: 10.1111/codi.14944] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
5 Mowat C, Digby J, Strachan JA, McCann RK, Carey FA, Fraser CG, Steele RJ. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care. Ann Clin Biochem 2021;58:211-9. [PMID: 33334134 DOI: 10.1177/0004563220985547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 [DOI: 10.1101/2020.05.15.20077909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Nicholson BD, James T, Paddon M, Justice S, Oke JL, East JE, Shine B. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.Aliment Pharmacol Ther. 2020;52:1031-1041. [PMID: 32677733 DOI: 10.1111/apt.15969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
8 Rodríguez-Alonso L, Rodríguez-Moranta F, Maisterra S, Botargues JM, Berrozpe A, Ruíz-Cerulla A, Suris G, Camps B, Gornals JB, Guardiola J. The EPAGE guidelines are not an effective strategy for managing colonoscopies during the COVID-19 pandemic. Gastroenterol Hepatol 2021:S0210-5705(21)00009-1. [PMID: 33545240 DOI: 10.1016/j.gastrohep.2020.11.020] [Reference Citation Analysis]
9 Barnett KN, Clark GRC, Steele RJC, Fraser CG. Faecal Haemoglobin Estimated by Faecal Immunochemical Tests-An Indicator of Systemic Inflammation with Real Clinical Potential. Diagnostics (Basel) 2021;11:2093. [PMID: 34829442 DOI: 10.3390/diagnostics11112093] [Reference Citation Analysis]
10 D'Souza N, Georgiou Delisle T, Chen M, Benton S, Abulafi M;  NICE FIT Steering Group. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut. 2020;. [PMID: 33087488 DOI: 10.1136/gutjnl-2020-321956] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
11 Rodriguez-Alonso L, Rodriguez-Moranta F, Ruiz-Cerulla A, Arajol C, Serra K, Gilabert P, Ibañez-Sanz G, Camps B, Guardiola J. The use of faecal immunochemical testing in the decision-making process for the endoscopic investigation of iron deficiency anaemia. Clin Chem Lab Med 2020;58:232-9. [PMID: 31785194 DOI: 10.1515/cclm-2019-0203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fraser CG. Use of fecal immunochemical testing in patients presenting in primary care with lower GI symptoms. CMAJ 2020;192:E377. [PMID: 32392528 DOI: 10.1503/cmaj.74717] [Reference Citation Analysis]
13 Digby J, Strachan JA, Mowat C, Steele RJC, Fraser CG. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study. BMC Gastroenterol 2019;19:213. [PMID: 31829141 DOI: 10.1186/s12876-019-1135-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
14 Digby J, Cleary S, Gray L, Datt P, Goudie DR, Steele RJC, Strachan JA, Humphries A, Fraser CG, Mowat C. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.United European Gastroenterol J. 2020;8:559-566. [PMID: 32213041 DOI: 10.1177/2050640620913674] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]